¬
ÒCyclization and Rearrangement Products from Coupling
Reactions between Terminal o-Alkynylphenols
or o-ethynyl(hydroxymethyl)benzene
and 6-Halopurines.Ó
Berg, T. C.; Bakken, V.; Gundersen, L.-L.; Petersen, D. Tetrahedron 2006, 62, 6121-6131.
¬
Ò(+)-Agelasine D: Improved Synthesis and Evaluation of
Antibacterial and Cytotoxic Activities.Ó
Vik, A.; Hedner, E.; Charnock,
C.; Samuelsen, ¯.; Larsson, R.; Gundersen, L.-L.; Bohlin.
L. J. Nat. Prod. 2006,
69, 381-386.
¬
ÒSynthesis of Optically Active 6-Alkynyl- and
6-Alkylpurines as Cytokinin Analogs and Inhibitors of 15-Lipoxygenase; Studies
of Intramolecular Cyclization of 6- (Hydroxyalkyn-1-yl)purines.Ó
Berg, T. C.; Gundersen, L.-L.; Eriksen, A. B.; Malterud, K. E. Eur. J. Org.
Chem. 2005, 4988-4994.
¬
ÒSelective Anti-tubercular Purines. Synthesis and
Chemotherapeutic Properties of 6-Aryl- and 6-Heteroaryl-9-benzylpurines.Ó
Br¾ndvang, M.; Gundersen, L.-L. Bioorg. Med. Chem. 2005, 13, 6360-6373.
¬
Ò6-Cyclopropylpurines as Novel Potent Analogs of Cytokinins.Ó
BrŒthe, A.; Gundersen, L.-L.; Rise, F.; Eriksen, A. B. Plant Growth Regul. 2005, 24, 41-45.
¬
ÒElectrochemical Studies of Biologically Acteve
IndolizinesÓ.
Teklu, S.; Gundersen, L.-L.; Rise, F.; Tilset, M. Tetrahedron. 2005, 61, 4643-4656.
¬
ÒIndolizine 1-Sulfonates as Potent Inhibitors of
15-Lipoxygenase from Soybeans.Ó
Teklu, S.; Gundersen, L.-L.; Malterud, K. E.; Larsen, T.; Rise, F. Bioorg.
Med. Chem. 2005, 338, 159-166.
¬
ÒSynthesis and Antimycobacterial Activity of Agelasine
E and AnalogsÓ
Bakkestuen, A. K.; Gundersen, L.-L.; Petersen, P.; Utenova, B. T.; Vik, A. Org.
Biol. Chem. 2005, 3, 1025-1033.
¬
ÒSynthesis, Biological Activity and SAR of
Antimycobacterial 9-Aryl-, 9-Arylsulfonyl- and 9-Benzyl-6-(2-furyl)purines.Ó
Bakkestuen, A. K.; Gundersen, L.-L, Utenova, B. T. J. Med. Chem. 2005, 48, 2710-2723.
¬ ÒSynthesis of (+)-Agelasine D from (+)-ManoolÓ Utenova, B. T.; Gundersen, L.-L. Tetrahedron Lett. 2004, 45, 4233-4235.
¬
ÒIndolizines as Novel Potent Inhibitors of
15-Lipoxygenase" Gundersen. L.-L.; Malterud, K. E.; Negussie, A. H.; Rise,
F.; Teklu, S.; ¯stby, O. B.
Bioorg. Med. Chem. 2003, 11, 5409-5419.
¬
ÒAntimycobacterial Activity of 1-Substituted IndolizinesÓ
Gundersen. L.-L.; Negussie, A. H.; Rise, F.; ¯stby, O. B.
Arch. Pharm. Pharm. Med. Chem. 2003,
336, 191-195.
¬
ÒRegioselective N-9 Arylation
of Purines Employing Arylboronic Acids in the Presence of Cu(II).Ó Bakkestuen,
A. K.; Gundersen, L.-L.
Tetrahedron Lett. 2003, 44, 3359-3362.
¬
ÒCytotoxic Activity of
6-Alkynyl- and 6-AlkenylpurinesÓ BrŒthe, A.; Gundersen, L.-L.; Nissen-Meyer,
J.; Rise, F.; Spilsberg, B.
Bioorg. Med. Chem. Lett. 2003, 13, 877-880.
¬
ÒSynthesis
of (+)-Trixagol, the Enantiomer of the (-)-Agelasine E the Terpenoid Side
Chain.Ó Bakkestuen, A. K.; Gundersen, L.-L.
Tetrahedron 2003, 59, 115-121.
¬
ÒCytotoxic and Antibacterial Effects of 2-Oxopurine derivatives.Ó
Andresen, G.; Gundersen, L.-L.; Nissen-Meyer, J.; Rise, F.; Spilsberg, B.
Bioorg. Med. Chem. Lett 2002, 12, 567-569.
¬
ÒSynthesis
and Antimycobacterial Activity of 6-Arylpurines; the Requirements for the N-9 Substituent in Active
Antimycobacterial Purines.Ó Gundersen, L.-L.; Nissen-Meyer, J.; Spilsberg, B.
J. Med. Chem.
2002, 45, 1383-1386. Link
¬
ÒAntioxidant
Activity of Synthetic Cytokinin Analogs: 6-Alkenyl and 6-Alkynylpurines as
Novel 15-Lipoxygenase InhibitorsÓ BrŒthe, A.; Andresen, G.; Gundersen, L.-L.;
Malterud, K. E.; Rise, F.
Bioorg. Med. Chem. 2002, 10, 1581-1586.
¬
ÒSynthesis
of 5-Substituted Pyrrolo[1,2-b]pyridazines with Antioxidant PropertiesÓ ¯stby,
O. B.; Gundersen, L.-L.; Rise, F.; Antonsen, ¯.; Fosnes, K.; Larsen, V.; Bast,
A.; Custers, I.; Haenen, G. R. M. M.
Arch. Pharm. Pharm. Med. Chem. 2001, 334, 21-24.
¬
ÒSynthesis
of 6-Substituted 2-Purinones with Potential Cytokinin Activity.Ó Andresen, G.;
Dalhus, B.; Eriksen, A.B. Gundersen, L.-L.; Rise, F.
J. Chem. Soc., Perkin Trans. 1. 2001, 1662-1672.
Link
¬
Ò9-(Phenylmethyl)-6-thienyl-9H-purineÓ Mazumdar, P. A.;
Das, A. K.; Bakkestuen, A. K.; Gundersen, L.-L., Bertolasi, V.
Acta. Cryst., 2001, E57, o1052-o1054.
¬
ÒSynthesis of 2-Oxopurine Adducts with Structural Resemblance to
Efavirenz and DPC 961 as Potential NNRT-InhibitorsÓ Andresen, G.; Gundersen,
L.-L.; Rise, F.
ARCIVOC 2001, Part (x), 35-45.
Link
___________________________________________________________
Last
updated May 2006, Lise-Lotte Gundersen